Test your knowledge of Follicular Lymphoma transformed to DLBCL

Which of the following is a potential treatment option that can be used in the relapsed/refractory setting for patients with follicular lymphoma transformed to DLBCL who are NOT eligible for autologous stem cell transplant?
Epcoritamab
Loncastuximab
Selinexor
All the above
Which of the following CAR T-cell therapies is NOT currently recommended for patients with follicular lymphoma transformed to DLBCL?
Axicabtagene ciloleucel
Tisagenlecleucel
Lisocabtagene maraleucel
Ciltacabtagene autoleucel
Which of the following is an effective second-line treatment option for patients with follicular lymphoma transformed to DLBCL who ARE candidates for HDT/ASCR?
R-ICE (rituximab, ifosfamide, carboplatin, and etoposide)
Polatuzumab vedotin in combination with bendamustine and rituximab
Tafasitamab plus lenalidomide
CEOP (cyclophosphamide, etoposide, vincristine, prednisone)
{"name":"Test your knowledge of Follicular Lymphoma transformed to DLBCL", "url":"https://www.poll-maker.com/QEY7QDU62","txt":"Which of the following is a potential treatment option that can be used in the relapsed\/refractory setting for patients with follicular lymphoma transformed to DLBCL who are NOT eligible for autologous stem cell transplant?, Which of the following CAR T-cell therapies is NOT currently recommended for patients with follicular lymphoma transformed to DLBCL?, Which of the following is an effective second-line treatment option for patients with follicular lymphoma transformed to DLBCL who ARE candidates for HDT\/ASCR?","img":"https://www.poll-maker.com/3012/images/ogquiz.png"}
Tools: Poll Maker | Quiz Maker | Super Surveys